Replies to post #229212 on Anavex Life Sciences Corp (AVXL)

[Gernee20]

Curious McM, if Rett topline is due mid year, how would we have revenue in 6-9 months? Seems like an unrealistic timeline as they need to complete/submit NDA which takes 3-6 months, then FDA review which is 3-6 months.

My projection for revenue is 16-20 months from now, roughly mid 2021

[polarbear77]

Rett Syndrome Association of Australia - RSAA posted this morning on Facebook:

“Another step closer.......


https://www.anavex.com/anavex-life-sciences-issued-new-u-s-patent-for-anavex2-73-treatment-of-neurodevelopmental-disorders-including-rett-syndrome-and-multiple-sclerosis/?fbclid=IwAR3IJAx2cm4tWMWMGOqvYgFdV1Nc6jzK6KL6-7n_bj7-BzD0PRcZufLK4D0

“

[Amatuer17]

We will be lucky if the Rett enrollment completes by mid year.

Rett is long journey - let’s get PDD enrollment completed and it will give some bump to SP.
Rett and AZ will not give any trigger soon.